DrewMoghanakiMD
Radiation Oncology • Los Angeles, CAThoracic Cancer
Professor | Chief of Thoracic Oncology | UCLA Department of Radiation Oncology
Dr. Moghanaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Center
200 Medical Plaza , Suite 165-47
Los Angeles, CA 90095Phone+1 310-794-2177Fax+1 310-794-2177
Summary
- Dr. Drew Moghanaki is a radiation oncologist at UCLA. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 15 years. He specializes in thoracic cancer and is experienced in lung cancer and stereotactic body radiation therapy. He has more than 80 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2003 - 2007
Vanderbilt University Medical CenterInternship, Surgery, 2002 - 2003
Vanderbilt University School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2021 - 2025
GA State Medical License 2018 - 2022
VA State Medical License 2008 - 2020
TN State Medical License 2011 - 2012
PA State Medical License 2003 - 2008
DE State Medical License 2004 - 2005- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Clinical Trials
- Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury Start of enrollment: 2007 Apr 01
- Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases Start of enrollment: 2011 Aug 01
- Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 267 citationsContemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical ProstatectomyRahul D. Tendulkar, Shree Agrawal, Tianming Gao, Jason A. Efstathiou, Thomas M. Pisansky
Journal of Clinical Oncology. 2016-10-23 - 13 citationsSurgery versus SABR for NSCLCDrew Moghanaki, Tomer Z. Karas
The Lancet. Oncology. 2013-11-01 - 42 citationsSalvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy—A Multi-Institutional Observational StudyThomas M. Pisansky, Shree Agrawal, Daniel A. Hamstra, Bridget F. Koontz, Stanley L. Liauw
International Journal of Radiation Oncology, Biology, Physics. 2016-12-01
Journal Articles
- Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological FeaturesRahul D. Tendulkar, Kevin L. Stephans, Stanley L. Liauw, Robert B. Den, Shre Agrawal, Mitchel S. Anscher, Jason A. Efstathiou, Thomas M. Pisansky, Jason W. Hearn, Jef ..., JAMA
Authored Content
- Management of Metastatic Spinal Cord Compression Among Veterans Health Administration Radiation OncologistsMarch 2018
Press Mentions
Researchers Awarded $2.5 Million Grant to Increase Lung Cancer Screenings in Underserved CommunitiesNovember 4th, 2024- SBRT: Alternative to Surgery in Early Stage Lung Cancer?April 5th, 2023
- SBRT: Alternative to Surgery in Early Stage Lung Cancer?April 5th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
